Sorrento Therapeutics Company

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Invests into

Technology: Others
Industry: PharmTech
Headquarters: San Diego, California, United States
Founded Date: 2006
Employees Number: 101-250
Funding Status: IPO
Investors Number: 1
Total Funding: 262568495 USD
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-10-09
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership